Nesina Lawsuit

 FDA safety review has found that type 2 diabetes medicines containing saxagliptin and alogliptin may increase the risk of heart failure, particularly in patients who already have heart or kidney disease. As a result, FDA is adding new warnings to the drug labels about this safety issue.

Saxagliptin and alogliptin are part of the class of dipeptidyl peptidase-4 (DPP-4) inhibitor drugs, which are used with diet and exercise to lower blood sugar in adults with type 2 diabetes.

Nesina Heart Failure

Nesina FDA WARNING

Nesina Heart Failure Lawsuit

Call Toll Free 1-800-883-9858 or CLICK HERE -> FREE CASE REVIEW